CRESSAN (CRESSAN) Fair Value & Analysis
IN · Market cap ₹2.2B
Fair value as of: Jul 5, 2026
From 9 valuation models · updated today
Share price −7.7% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹1.80 – ₹5.12 · fair‑value band ₹0.5100 – ₹0.9500 · the ₹2.41 price screens above the ₹0.7300 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
CRESSAN (CRESSAN) currently trades at ₹2.41, while our model-based Fair Value estimate is ₹0.7300 — implying the stock looks roughly 69.7% overvalued today. We read business quality at 33/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Trailing-twelve-month revenue stands at ₹868M. Fundamentals as of Jul 5, 2026
Our scenario range runs from ₹0.5100 (bear case) to ₹0.9500 (bull case); at ₹2.41, the current price sits above that range. The share trades about 55% below its 52-week high and 34% above its 52-week low, currently below its 200-day average.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
CRESSAN reported revenue of ₹325M in FY2024 versus ₹933K in FY2020, a compound +331.9%/yr. Reported net income was ₹6.8M in FY2024, compounding +250.7%/yr from FY2020.
Is CRESSAN fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is CRESSAN (CRESSAN) undervalued?
What is the fair value of CRESSAN?
What is the quality score of CRESSAN?
What is the revenue of CRESSAN (CRESSAN)?
What is the net profit margin of CRESSAN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.